Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

Lymph node location system during sentinel biopsy procedure

Número de PMA: P160053 · 2026-05-18

SolicitanteEndomagnetics Ltd.,
Fecha de decisión2026-05-18
Número PMAP160053
Código de productoPUV
Clase del dispositivoClase 3
Especialidad médicaU
Comité asesorSU

Resumen del dispositivo

Lymph node location system during sentinel biopsy procedure is the device name listed in this FDA 510(k) record. The listed applicant is Endomagnetics Ltd.,. It received FDA 510(k) clearance on 2026-05-18. The device is classified under product code PUV. It was reviewed by the SU advisory panel.

Preguntas frecuentes

What is the Lymph node location system during sentinel biopsy procedure?

Lymph node location system during sentinel biopsy procedure is a medical device that received FDA 510(k) clearance on 2026-05-18. The listed applicant is Endomagnetics Ltd.,.

When did Lymph node location system during sentinel biopsy procedure receive FDA 510(k) clearance?

The clearance date for Lymph node location system during sentinel biopsy procedure can be found in the official FDA records.

Who is the listed applicant for Lymph node location system during sentinel biopsy procedure?

The FDA 510(k) record lists Endomagnetics Ltd., as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Lymph node location system during sentinel biopsy procedure?

The FDA product code for Lymph node location system during sentinel biopsy procedure is PUV.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑